Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
-
30th Jun 16 Source: CRO
- €5 billion turnover
- 13,300 employees
- 3 more years available »
Ranking
By Turnover
(€4.1 billion)- 23rd in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 19th in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.1 billion
Employees
- Uwe Röhrhoff CEO/Managing Director
Latest News
- Jan 18 High Court rules in case of four Caribbean-registered firms
- Jan 18 Travelodge boosts pretax profits at Tifco to €11.8m in 2017
- Jan 18 European shares rise to highest in six weeks
- Jan 18 Holiday home management company sues operators at estate over maintenance
- Jan 18 Spain plans 3% ‘Google’ tax on large tech companies